BASF has joined forces with GEA Niro in cGMP spray drying for custom synthesis pharma production
BASF’s Business Unit Pharma Ingredients & services has entered into a cooperation with GEA Niro, which will allow BASF to make cGMP (current Good Manufacturing Practice) spray drying tests and pilot productions of active pharmaceutical ingredients (APIs) at GEA Niro’s Pharma Test Station in Copenhagen.
Spray drying is an important technology to improve the bioavailability of poorly soluble APIs. The spray drying technology can be applied in pharmaceutical production to obtain several benefits including increased bioavailability, controlled release or taste masking, and to produce fine powders for inhalation or other applications. Through this alliance, BASF will add spray drying of APIs and formulations to its offerings as a provider of custom synthesis services for small molecules to the pharmaceutical industry.
By combining BASF’s state of the art custom synthesis capabilities and expertise in excipients with GEA Niro’s spray drying know-how and cGMP facilities, BASF has created a unique value proposition for its pharmaceutical customers.
Dr. Folker Ruchatz, BASF`s Director of Global Business Management Custom Synthesis: “BASF has already substantial know-how in spray drying. With this cooperation we add to our portfolio the ability to offer a cGMP facility. Teaming up with GEA Niro gives us access to a superior facility, and by working with the leading supplier of spray drying technology worldwide, we can provide the best solutions to our customers' needs sustainably.”
Topics
Organizations
Other news from the department business & finance
These products might interest you

Pharmaceutical Substances by Thieme Verlag
Look up Industrial Syntheses of 2,600 APIs
Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances

AZURA Purifier + LH 2.1 by KNAUER
Preparative Liquid Chromatography - New platform for more throughput
Save time and improve reproducibility during purification

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Last viewed contents
BASF and three top European universities team up on functional materials research - Goal: innovation in multi-materials and systems

Young start-up team develops new reference materials for direct microanalysis of solids - Setting new standards in solids analysis

Progress in the application of spin effects in graphene: from the metal to the semiconductor world
Doxycycline
Category:EC_1.7.1
P2X_receptor
Finally, a way to authenticate premium chocolate
Category:EC_1.7.7
